(Administrative Core A, Hascall) The Administrative Core of our proposed Cleveland Clinic Program of Excellence in Glycosciences (CC-PEG) comprises the Director, Vincent Hascall, PhD, the Associate Director, Ronald Midura, PhD, and Lisa MacDowell Mooney, Core Administrator. They will provide oversight for all the activities of the CC-PEG, including: 1) arranging and monitoring: (a) the bi-weekly meetings of the PEG Research Team (project and core directors, and laboratory investigators of all the projects), (b) the meetings of the Executive Committee;(c) the biannual meetings of the Internal Advisory Board, and (d) the yearly visits of selected members of the External Advisory Board (to be determined) in years 1-3 and the combined External Advisory Board visit (year 4);2) monitoring progress of the projects;3) providing oversight of the budget and expenditures of the Shared Resources Core B and the Glycosciences Skills Development Core C;4) working with the Skills Development Core C to organize the agendas for the Visiting Scholars Program and the trips of the new postdoctoral fellows to the Complex Carbohydrate Research Center at the University of Georgia in Athens, Georgia for their workshops;5) preparing the annual progress reports;and 6) coordinating communications with the NHLBI oversight staff and with the Principal Investigators in the other PEGs.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL107147-04
Application #
8669091
Study Section
Special Emphasis Panel (ZHL1-CSR-H)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
4
Fiscal Year
2014
Total Cost
$98,055
Indirect Cost
$35,215
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Hope, Chelsea; Foulcer, Simon; Jagodinsky, Justin et al. (2016) Immunoregulatory roles of versican proteolysis in the myeloma microenvironment. Blood 128:680-5
Benz, Brian A; Nandadasa, Sumeda; Takeuchi, Megumi et al. (2016) Genetic and biochemical evidence that gastrulation defects in Pofut2 mutants result from defects in ADAMTS9 secretion. Dev Biol 416:111-22
Dong, Yifei; Arif, Arif; Olsson, Mia et al. (2016) Endotoxin free hyaluronan and hyaluronan fragments do not stimulate TNF-α, interleukin-12 or upregulate co-stimulatory molecules in dendritic cells or macrophages. Sci Rep 6:36928
Abbadi, Amina; Lauer, Mark; Swaidani, Shadi et al. (2016) Hyaluronan Rafts on Airway Epithelial Cells. J Biol Chem 291:1448-55
Apte, Suneel S (2016) Anti-ADAMTS5 monoclonal antibodies: implications for aggrecanase inhibition in osteoarthritis. Biochem J 473:e1-4
Petrey, Aaron C; Obery, Dana R; Kessler, Sean P et al. (2016) Hyaluronan Depolymerization by Megakaryocyte Hyaluronidase-2 Is Required for Thrombopoiesis. Am J Pathol 186:2390-403
Janssen, Lauriane; Dupont, Laura; Bekhouche, Mourad et al. (2016) ADAMTS3 activity is mandatory for embryonic lymphangiogenesis and regulates placental angiogenesis. Angiogenesis 19:53-65
Soroosh, Artin; Albeiroti, Sami; West, Gail A et al. (2016) Crohn's Disease Fibroblasts Overproduce the Novel Protein KIAA1199 to Create Proinflammatory Hyaluronan Fragments. Cell Mol Gastroenterol Hepatol 2:358-368.e4
Matuska, Brittany; Comhair, Suzy; Farver, Carol et al. (2016) Pathological Hyaluronan Matrices in Cystic Fibrosis Airways and Secretions. Am J Respir Cell Mol Biol 55:576-585
Petrey, Aaron C; de la Motte, Carol A (2016) Thrombin Cleavage of Inter-α-inhibitor Heavy Chain 1 Regulates Leukocyte Binding to an Inflammatory Hyaluronan Matrix. J Biol Chem 291:24324-24334

Showing the most recent 10 out of 90 publications